C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2006
11/30/2006	US20060270833 Peptide complex
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270627 Synthetic oligomannosides, preparation and uses thereof
11/30/2006	US20060270604 Pharmaceutical preparations of Fn3 polypeptides for human treatments
11/30/2006	US20060270593 Novel molecules of the PYRIN/NBS/LRR protein family and uses thereof
11/30/2006	US20060270045 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
11/30/2006	US20060270003 Nucleotide sequences coding imterleukin-17 polypeptide for use in diagnosis, prevention and treatment of bone, autoimmune, skin and inflammatory disorders
11/30/2006	US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use
11/30/2006	US20060269990 Process for the preparation of recombinant polypeptides
11/30/2006	US20060269989 Process for producing antibodies
11/30/2006	US20060269977 Recombinant antibody recognizing dioxin and gene encoding the antibody
11/30/2006	US20060269976 Method for reducing lysozyme enzymatic activity
11/30/2006	US20060269970 Method for a fully automated monoclonal antibody-based extended differential
11/30/2006	US20060269967 Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269951 Inhibitors of autoinducer transporters
11/30/2006	US20060269926 Novel dyes for the detection or quantification of desirable target molecules
11/30/2006	US20060269917 Compositions, splice variants and methods relating to colon specific gene and proteins
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269572 Accelerated vaccination
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269561 Compositions and methods for treatment of non-hodgkins lymphoma
11/30/2006	US20060269559 Novel human histone deacetylases
11/30/2006	US20060269557 Humanized anti-prostate stem cell antigen monoclonal antibody
11/30/2006	US20060269556 Mast cell activation using siglec 6 antibodies
11/30/2006	US20060269555 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders
11/30/2006	US20060269554 DR5 antibodies and uses thereof
11/30/2006	US20060269553 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic
11/30/2006	US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
11/30/2006	US20060269551 Reducing interleukin (IL-20) induced inflammation by administering antibody, fragment or single chain antibody; adult respiratory disease, psoriasis, eczema, dermatitis, septic shock, multiple organ failure, pneumonia, inflammatory bowel disease, arthritis, asthma, ulcerative colitis, Crohn*s disease
11/30/2006	US20060269550 Anti-ghrelin fab antibodies
11/30/2006	US20060269547 Humanized anti-CD3 specific antibodies
11/30/2006	US20060269546 Androgen-regulated PMEPA1 gene and polypeptides
11/30/2006	US20060269545 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11/30/2006	US20060269541 S.agalactiae antigens I + II
11/30/2006	US20060269540 Targeted cd1d molecules
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269532 Compositions and methods for the therapy and diagnosis of prostate cancer
11/30/2006	US20060269516 Interferon-IgG fusion
11/30/2006	US20060269515 Interleukin-2 muteins
11/30/2006	CA2631556A1 Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof
11/30/2006	CA2610357A1 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	CA2610340A1 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
11/30/2006	CA2609731A1 A method for the production of a monoclonal antibody to cd20 for the treatment of b-cell lymphoma
11/30/2006	CA2609682A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/30/2006	CA2609593A1 Anti-cd16 binding molecules
11/30/2006	CA2609480A1 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
11/30/2006	CA2607375A1 Method for the purification of antibodies
11/29/2006	EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides
11/29/2006	EP1726654A2 Polypeptide of n-acetylglucosamine-6-0-sulfotransferase and DNA encoding the same
11/29/2006	EP1726650A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/29/2006	EP1726313A1 Drug for preventing and treating arteriosclerosis
11/29/2006	EP1725870A1 Anti-lipid rafts antibodies
11/29/2006	EP1725666A2 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
11/29/2006	EP1725659A2 Natural igm antibodies and inhibitors thereof
11/29/2006	EP1725657A1 Prostatic acid phosphatase antigens
11/29/2006	EP1725587A2 Compositions and methods for detection of single molecules
11/29/2006	EP1725586A2 Partially loaded antibodies and methods of their conjugation
11/29/2006	EP1725585A2 Method for producing antibodies
11/29/2006	EP1725265A2 Calicheamicin conjugates by antibody deglycosylation
11/29/2006	EP1725264A2 Antibody calicheamicin conjugates for passive targeting
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725254A2 Anti-cd3 and antigen-specific immunotherapy to treat autoimmunity
11/29/2006	EP1725249A2 Monomethylvaline compounds capable of conjugation to ligands
11/29/2006	EP1725111A2 Methods and compositions for inhibition of metastasis
11/29/2006	EP1613205A4 Erbb surface receptor complexes as biomarkers
11/29/2006	EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides
11/29/2006	EP1478381A4 Use of soluble gamma delta t cell receptors for regulating t cell function
11/29/2006	EP1423708B1 Compositions and methods for aa4rp assay
11/29/2006	EP1366080B1 Natural antibodies active against hiv virus
11/29/2006	EP1353953B1 Mu-1, member of the cytokine receptor family
11/29/2006	EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006	EP1299724B1 Synthetic peptide for neurological disorders
11/29/2006	EP1290164B1 Human twik-8 molecules and uses thereof
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1220911B1 P-glycoproteins and uses thereof
11/29/2006	EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006	EP1198251B1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent
11/29/2006	EP1196598B1 Dsp-3 dual-specificity phosphatase
11/29/2006	EP1141026B1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
11/29/2006	EP1117692B1 Tie2 agonist antibodies
11/29/2006	EP1114861B1 Ly6h gene
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0937251B1 Purification of antigen-specific t cells
11/29/2006	EP0915982B1 Drosophila melanogaster p70 s6 kinase
11/29/2006	EP0821695B1 Antibody purification by low-ph hydrophobic interaction chromatography
11/29/2006	EP0785716B1 Cytokine designated lerk-6
11/29/2006	EP0556292B2 Hepatitis c virus asialoglycoproteins
11/29/2006	CN1871518A Method of detecting hepatitis c virus
11/29/2006	CN1871517A Methods and reagents for the rapid and efficient isolation of circulating cancer cells
11/29/2006	CN1871359A Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
11/29/2006	CN1871259A Improved antibodies having altered effector function and methods for making the same
11/29/2006	CN1869235A Method for modifying plant morphology, biochemistry and physiology
11/29/2006	CN1869225A Application of leucocythemia related to gene ASH2L in leukemia molecule classification diagnosis
11/29/2006	CN1869207A Rat antihuman macrephage migration inhibiting factor monoclone antibody and its application
11/29/2006	CN1869073A Antibody of EPSPS enzyme and its prepuration method and special antigen and application
11/29/2006	CN1869070A High efficiency low poison immune toxin and its preparation method and application
11/29/2006	CN1869069A Recombination enterovirus 71 type neutralization antibudy and its use
11/29/2006	CN1868545A Improved vaccines

1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 1494